Companies › BNGO
BioNano Genomics Inc (BNGO)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001411690 · EDGAR filings · Updated 2026-06-24
BioNano Genomics Inc (BNGO) has reported institutional ownership of 7.8%, with 31 institutional managers holding positions valued at $1.02M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-24 — Current report (8-K) filed
- 2026-06-05 — Current report (8-K) filed
- 2026-06-03 — Insider transaction reported (Form 4)
- 2026-06-03 — Insider transaction reported (Form 4)
- 2026-06-03 — Insider transaction reported (Form 4)
- 2026-06-03 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, BioNano Genomics Inc has 31 institutional holders and institutional ownership of 7.8%.
Insider activity
Insiders reported 13 transactions (0 buys, 0 sells) across 5 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
CHARMING MEDICAL LTD (MCTA) · ALLARITY THERAPEUTICS INC (ALLR) · ENVVENO MEDICAL CORPORATION (NVNO) · Icecure Medical Ltd (ICCM) · JYONG BIOTECH LTD (MENS) · Beyond Air Inc (XAIR)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-24.